AGITG Trial News

The AGITG currently has eight  studies open to recruitment and ten  studies in follow up.

The  table below details  the trials that  are currently  accruing patients.

Recruited

Target

ACTICCA-1- Gallbladder carcinoma 2 50
ALT-GIST- GI Stromal Tumour 18 60
ASCOLT — Colorectal cancer 217 300
CONTROL NETs — NeuroEndocrine Tumour 56 72
INTERAACT — Anal cancer 1 20
INTEGRATE II –  Gastro-Oesophageal 18 350
NABNEC  — NeuroEndocrine Tumour 5 70
TOP GEAR — Stomach cancer 175 752

Recruitment figures to end  May 2017.

 

Trial Results Lay Summaries (click on the links below):

ALaCaRT

ATTACHE

ATTAX-3

GAP

ICECREAM

INTEGRATE

TACTIC

TOP GEAR

CO.17

EORTC 62024